Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Reuters Investment Profile
Provider: Directors Deals Ltd.
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Coloplast raises FY 2013/2014 revenue growth guidance

Wednesday, 29 Jan 2014 05:35am EST 

Coloplast A/S:Says now expects FY 2013/2014 organic revenue growth of around 8 percent and of around 6 percent in Danish crowns, while the previous guidance was of around 7 percent organic growth and around 5 percent in Danish crowns.Says the EBIT margin guidance is still around 33 percent, both at constant exchange rates and in Danish crowns.FY 2012/2013 revenue was 11,635 million Danish crowns.FY 2013/2014 revenue 12,281 million Danish crowns-Thomson Reuters I/B/E/S Estimates. 

Company Quote

23 Dec 2014